Announcements
- Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
- Exagen Announces Campaign for Lupus Awareness Month
- Exagen to Announce First Quarter 2024 Results on May 13, 2024
- Exagen Inc. Announces Changes to the Board of Directors
- Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
- Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
- Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
- Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
- Exagen Inc. Reports Strong Third Quarter 2023 Results
More ▼
Key statistics
As of last trade, Exagen Inc (E08A:STU) traded at 1.78, 44.72% above the 52 week low of 1.23 set on Apr 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.74 |
---|---|
High | 1.78 |
Low | 1.73 |
Bid | 1.74 |
Offer | 1.91 |
Previous close | 1.73 |
Average volume | 0.00 |
---|---|
Shares outstanding | 17.37m |
Free float | 8.95m |
P/E (TTM) | -- |
Market cap | 33.88m USD |
EPS (TTM) | -1.09 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼